oral glp-1 medications fda approved The obesity treatment revolution is about to take its most consequential step yet. Eli Lilly's candidate orforglipron is on track for approval this month — positioning it as one GLP-1 Oral Tablet — Zera

Understanding Retatrutide:- Retatrutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications commonly used to treat type 2 diabetes

President, iNutritionals, Inc

The findings are encouraging: Over 70% of patients who discontinued GLP-1 therapy maintained at least a 5% reduction in body weight after 12 months, and more than half maintained a loss of at least 10%

Individuals who smoked cigarettes showed significantly greater reductions in cigarettes per day when receiving semaglutide compared to the placebo group 22

On the other hand, the rates of occurrence of hypoglycemia in the active drug groups were similar (or even lower) to those of the placebo groups